FLNA Gene Otopaladigital Syndrome Type 2 Genetic Test
Test Name: FLNA Gene Otopaladigital Syndrome Type 2 Genetic Test
Components: FLNA gene analysis
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Ear Nose Throat Disorders
Doctor: ENT Doctor
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for SLC52A3 Gene Brown-Vialetto-Van Laere syndrome 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC52A3 Gene Brown-Vialetto-Van Laere syndrome 1 NGS Genetic DNA Test gene SLC52A17
Test Details
The FLNA Gene Otopaladigital Syndrome Type 2 NGS Genetic Test is a genetic test that analyzes the FLNA gene for mutations associated with Otopaladigital Syndrome Type 2. This rare genetic disorder is characterized by skeletal abnormalities, hearing loss, and intellectual disability.
The FLNA gene provides instructions for making the filamin A protein, which is essential for the development and maintenance of various tissues in the body, including the skeleton and brain.
The NGS (Next-Generation Sequencing) genetic test uses advanced sequencing technology to analyze the FLNA gene for mutations. By detecting specific changes in the gene’s DNA sequence, this test can help confirm a diagnosis of Otopaladigital Syndrome Type 2.
Additionally, the test provides valuable information for genetic counseling and management of the disorder. It is typically ordered by healthcare professionals such as geneticists or genetic counselors, who will interpret the results and provide appropriate recommendations based on the individual’s specific situation.
It is important to note that genetic testing can have implications for the individual and their family members. Therefore, it is crucial to have a thorough understanding of the test and its potential outcomes before proceeding.
Test Name | FLNA Gene Otopaladigital syndrome type 2 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Ear Nose Throat Disorders |
Doctor | ENT Doctor |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for SLC52A3 Gene Brown-Vialetto-Van Laere syndrome 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC52A3 Gene Brown-Vialetto-Van Laere syndrome 1 NGS Genetic DNA Test gene SLC52A17 |
Test Details |
FLNA Gene Otopaladigital syndrome type 2 NGS Genetic Test is a genetic test that analyzes the FLNA gene for mutations associated with Otopaladigital syndrome type 2. Otopaladigital syndrome type 2 is a rare genetic disorder characterized by skeletal abnormalities, hearing loss, and intellectual disability. The FLNA gene provides instructions for making the filamin A protein, which plays a role in the development and maintenance of various tissues in the body, including the skeleton and brain. The NGS (Next-Generation Sequencing) genetic test uses advanced sequencing technology to analyze the FLNA gene for mutations. This test can identify specific changes in the gene’s DNA sequence that may be responsible for causing Otopaladigital syndrome type 2. By detecting these mutations, the test can help confirm a diagnosis of the condition and provide valuable information for genetic counseling and management of the disorder. It is important to note that this test is typically ordered by a healthcare professional, such as a geneticist or genetic counselor, who will interpret the results and provide appropriate recommendations based on the individual’s specific situation. Genetic testing can have implications for the individual and their family members, so it is important to have a thorough understanding of the test and its potential outcomes before proceeding. |